Assyro AI

Orange Book product · Brand (NDA)

VASOPRESSIN IN SODIUM CHLORIDE 0.9%

VASOPRESSIN

Brand (NDA)NDA 217569RX BAXTER HLTHCARE CORP

At a glance

Sep 29, 2023

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 29, 2023

    2 yr 9 mo ago

  2. Today

  3. Patent 12447190 expires

    Listed drug product patent expiration.

    Sep 27, 2044

    in 18 yr 7 mo

Pharmaceutical detail

Active ingredient

VASOPRESSIN

Strength

20UNITS/100ML (0.2UNITS/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 217569

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12447190Sep 27, 2044in 18 yr 7 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.